AOAdrian Mark Owen

Adrian Mark Owen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adrian Mark Owen has a total of 270 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex differences in cognitive and psychological outcomes following acute ischemic cardiac events: a cross-sectional study

    by Sophie Kelly, Loretta Norton, Adrian Owen, Derek B. Debicki

    Background: Sex differences in cardiovascular outcomes are well established; however, sex-specific cognitive and psychological recovery following acute ischemic cardiac events remains underexplored. This study examined sex differences in early cognitive and psychological outcomes following out-of-hospital cardiac arrest (OHCA) and ST-elevation myocardial infarction (STEMI). Methods: Fifty-eight patients hospitalized for OHCA or STEMI completed a web-based cognitive battery assessing memory, reasoning, and verbal abilities, along with validated measures of anxiety and depression, approximately 24–48 h prior to discharge. Cognitive performance was compared to age- and sex-matched normative data. Group differences were assessed using one-sample and independent samples t-tests, non-parametric equivalents where appropriate, and multivariate analysis of variance (MANOVA) to evaluate sex effects across cognitive domains. Results: Participants demonstrated significant cognitive impairment across all domains relative to normative controls. While cognitive performance did not differ significantly by sex, female patients reported substantially higher levels of anxiety and depressive symptoms than male patients, with mean scores exceeding clinical screening thresholds. Conclusions: Acute survivors of ischemic cardiac events demonstrated broad cognitive impairment in the early recovery period, but the most clinically salient sex difference was observed in psychological outcomes, whereby female patients reported significantly greater symptoms during the earliest stage of recovery. These findings highlight the importance of early and routine mental health screening and targeted psychosocial support for female survivors of ischemic cardiac events.

  • Open Access

    Mapping basal ganglia circuitry in altered states of consciousness: from pathology to pharmacology

    by Dorottya Szocs, Andrea I Luppi, Peter Coppola, Ram Adapa, Guy B Williams, Judith Allanson, John D Pickard, Adrian M Owen, Lorina Naci, David K Menon, et al.

    The precise neuromodulatory mechanisms underlying consciousness and its disorders, despite growing evidence in both animals and humans, remain poorly understood at the subcortical level. The basal ganglia, a key component of the cortico-basal ganglia-thalamo-cortical loop, are known to play a crucial role in mediating consciousness and behavioural responsiveness to the environment. Here, we aimed to present a comprehensive mapping of the distinct contributions of basal ganglia nuclei and their associated neurotransmitter systems in pharmacologically induced and pathological loss of responsiveness. We used functional MRI to provide a systematic investigation of 9 major nuclei (putamen, caudate, nucleus accumbens, globus pallidus external, globus pallidus internal, substantia nigra pars compacta, substantia nigra pars reticulata, ventral pallidus, and subthalamic nucleus) and their functional relationship with 19 major neurotransmitter systems in loss of responsiveness, in both healthy volunteers under propofol anaesthesia (n = 16) and patients with disorders of consciousness (DOC) (i.e. minimally conscious, unresponsive wakefulness syndrome) (n = 22). We found that in pharmacologically-induced loss of responsiveness, the functional connectivity changes of the putamen (Pu) correlated with the norepinephrine transporter (NET), and the globus pallidus external (GPe) with the serotonin transporter (5-HTT) and vesicular acetylcholine transporter (VAChT); additionally, altered connectivity in the ventral pallidum (VeP) was associated with the norepinephrine transporter (NET). In contrast, with pathological-induced loss of responsiveness, we found that connectivity changes of the caudate were associated with the serotonin transporter (5-HTT), dopamine transporter (DAT), and GABAA receptor, and connectivity changes of the substantia nigra pars compacta (SNc) were associated with the cannabinoid (CB1) receptor. Finally, we report that among all basal ganglia nuclei, a key dopamine-rich area of the basal ganglia—the substantia nigra—was found to have the largest DOC subgroup difference in functional connectivity, following stratification based on mental-imagery task responsiveness. Critically, we provide evidence that pharmacological and pathological loss of responsiveness involve distinct neurotransmitter system contributions across individual basal ganglia nuclei, offering a novel framework for targeted therapeutic interventions in patients with disorders of consciousness.

  • Open Access

    Neuroanatomical subtypes of Long COVID reveal distinct cognitive profiles alongside longitudinal brain changes

    by Angel Omar Romero-Molina, Betsabe McCord, Juan Fernandez-Ruiz, Adrian M. Owen, Carlos R. Hernandez-Castillo

    Background: Long COVID is characterized by persistent symptoms following SARS-CoV-2 infection, including cognitive deficits among its most disabling manifestations. However, their neurobiological basis is poorly understood. Previous neuroimaging studies reported structural brain alterations, but few have integrated cognitive assessment, network-based analyses, and longitudinal imaging to identify neurobiological subtypes. Methods: We studied 42 individuals with persistent post-COVID cognitive symptoms and 14 matched healthy controls using cognitive assessment and structural MRI. Multilayer brain networks were constructed from regional morphometric measures, and hierarchical clustering identified patient subgroups. Cross-sectional and longitudinal comparisons of brain structure, cognition, and function were performed, with exploratory brain–behavior correlations over six months. Results: Clustering identified two subgroups with distinct structural patterns. Compared with controls, one subgroup showed reduced gray matter density in cerebellar lobules VIIIa/VIIIb and the putamen (p < 0.05, TFCE-corrected), whereas the other showed no significant alterations. Cognitive differences between clusters did not survive multiple-comparison correction; however, several measures showed medium-to-large effect sizes (d = 0.70–1.01), suggesting meaningful cognitive differences requiring confirmation in larger cohorts. Longitudinal analyses revealed increased medial frontal gray matter density (p < 0.05) associated with visuospatial/executive performance. Conclusions: These exploratory findings suggest that post-COVID cognitive symptoms are associated with heterogeneous neurobiological profiles rather than a uniform pattern of impairment. Structural alterations involving cerebellar, striatal, and frontal regions may reflect distinct neuroanatomical phenotypes. Longitudinal findings suggest medial frontal structural reorganization with functional relevance. These findings support data-driven stratification for characterizing neurobiological heterogeneity in Long COVID and provide a foundation for future hypothesis-driven studies.

  • Open Access

    Assessing cognition and quality of life in people with epilepsy: A feasibility study for mild and marked cognitive impairment

    by Hannah G. Gray, Karnig Kazazian, Matthew Kolisnyk, Conor J. Wild, Adrian M. Owen, Teneille E. Gofton

  • Open Access

    The blueprint of human functional architecture shifts from cognition to anatomy during perturbations of consciousness

    by Andrea I Luppi, Dragana I Manasova, Justine Y Hansen, Zhen-Qi Liu, Asa Farahani, Yonatan Sanz Perl, Jakub Vohryzek, Daniel Golkowski, Andreas Ranft, Ruediger Ilg, et al.

    Consciousness and cognition arise from the ongoing interactions between brain regions. Synchronous fluctuations of fMRI signals may indicate that two brain regions perform similar cognitive functions, but neural interactions are also constrained by anatomical connectivity and regions' molecular, cytoarchitectonic, and metabolic profiles. Here we disentangle the respective contributions of ongoing cognition and multimodal neurobiological constraints in shaping functional connectivity. We jointly contextualise haemodynamic FC against eight distinct multimodal representations of the human connectome: (i) structural connectivity from diffusion tractography; (ii) spatial embedding; (iii) similarity of transcriptional profiles from gene expression; (iv) similarity of receptor profiles from Positron Emission Tomography; (v) laminar profile similarity from histology; (vi) correlated electrophysiological activity from magnetoencephalography; (vii) correlated metabolic activity from PET glucose uptake; (viii) coordinated activation across 123 cognitive operations from the NeuroSynth meta-analytic engine. We demonstrate that cognitive co-activation is the dominant predictor of inter-regional fMRI synchrony in the awake human brain, even when quantified using intracranial electrical stimulation. Crucially, this predominance of cognitive co-activation for shaping functional connectivity is systematically obliterated across five datasets of pharmacological and pathological perturbations of consciousness (chronic disorders of consciousness; anaesthesia with sevoflurane, propofol, or ketamine) when cognition is disconnected from the environment or altogether abolished. Altogether, we show that multimodal predictors of functional architecture shift away from cognitive co-activation and toward anatomical-molecular constraints during pharmacological and pathological perturbations of consciousness.


  • Open Access

    Neural Reconstruction in Disorders of Consciousness: Prospects and Emerging Challenges

    by Matthew Kolisnyk, Sidath Rankaduwa, Garima Gupta, Karnig Kazazian, Derek B. Debicki, Adrian M. Owen

    Reconstructing mental experience from brain activity is becoming increasingly feasible through advances in neuroimaging and deep learning. Neural signals have been translated into images, text, and speech and have been applied clinically to restore communication and movement in patients with motor paralysis. Extending reconstruction to patients with disorders of consciousness (DoCs) represents the next critical step. DoCs encompass conditions such as the vegetative and minimally conscious states, in which wakefulness is preserved but behavioral signs of awareness are absent, inconsistent, or difficult to interpret. These behavioral signs may not reflect patients’ underlying cognitive capacities, as neuroimaging studies have shown that a subset retains cognitive function. Reconstruction could offer insight into these otherwise inaccessible experiences and potentially restore communication. However, if applied incorrectly, reconstruction risks mischaracterizing a patient’s inner life and compromising their autonomy. To clarify the current landscape, this article reviews the development of reconstruction methods, their emerging clinical applications, and the distinct interpretive challenges associated with applying these approaches to DoCs. It then offers recommendations for evaluating reconstruction results, centered on identifying awareness, validating reconstruction models, and protecting patient autonomy. The aim is to support the responsible advancement of reconstruction and its potential to transform understanding of DoCs.

  • Open Access

    Early cognitive screening for individuals on the dementia continuum: A novel approach amid current trends

    by Diana M. Urian, Garima Gupta, Michael E. Battista, Conor J. Wild, Adrian M. Owen

    Mild cognitive impairment (MCI) is a critical transitional stage between normal aging and dementia that remains challenging to detect. Many traditional neuropsychological assessments designed for early detection of MCI are time-consuming, require specialized training and/or demonstrate limited validity, making them impractical for widespread use in primary care settings. This article is divided into two phases. The first phase provides a rapid review of the current landscape of cognitive screening tools, while the second presents a novel, fully automated, digital screener based on two tasks from the Creyos cognitive assessment platform. This novel screener has been designed, using machine learning, for rapid administration without clinical supervision. The preliminary findings demonstrate that our two-task screener effectively differentiates between cognitively normal individuals and those at risk of progression along the Alzheimer's disease continuum. Furthermore, validation analyses showed that the screener has high sensitivity and specificity, outperforming many conventional assessments. By offering a brief, accessible, and reliable alternative to standard screening tools, our screener has the potential to enhance early detection efforts and facilitate timely intervention, ultimately improving patient outcomes, reducing the burden on clinicians, and optimizing healthcare resources.


  • Open Access

    A thalamic perspective of (un)consciousness in pharmacological and pathological states in humans

    by Dorottya Szocs, Dian Lyu, Andrea I Luppi, Peter Coppola, Rebecca E Woodrow, Guy B Williams, Judith Allanson, John D Pickard, Adrian M Owen, Lorina Naci, et al.

    Currently, there is substantial ongoing discussion around the functional role of the thalamus in consciousness. What is missing in the literature, however, is a systematic investigation of the relevance of specific thalamic nuclei in pharmacologically and pathologically altered states of consciousness in humans. Using resting-state functional magnetic resonance imaging in both healthy anaesthetized volunteers (n = 16) and patients with disorders of consciousness (n = 22), we sought to identify which specific thalamic subregions in both cohorts may be differentially significant for loss of consciousness. Our findings revealed that, among all nuclei, the pulvinar was found to have the strongest functional connectivity change with loss of consciousness following anaesthesia, while demonstrating distinct functional connectivity patterns related to higher-order default mode and executive control networks. Remarkably, in loss of consciousness in disorders of consciousness patients, the ventral-latero-ventral was found to have the strongest connectivity change in comparison with healthy controls, while exhibiting discrete functional connectivity patterns related to higher-order default mode, executive control and frontoparietal networks. Furthermore, we provide evidence that this neural connectivity biomarker in patients also mirrored the changes observed at the behavioural level, which could have clinical implications for targeted deep brain stimulation in therapy for disorders of consciousness.